Can a 'Participatory' approach get more people screened for colon cancer?
NCT ID NCT06682650
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a method called NPT-PLA to help 20 primary care clinics better use a decision-making tool that encourages colorectal cancer screening. About 2,200 patients and staff will take part. The goal is to see if this approach leads to more screening orders and completions compared to usual quality improvement efforts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Participatory Learning in Action (PLA) combined with Normalization Process Theory (NPT)
- What this could lead to
- If successful, this could show how to effectively implement a colorectal cancer screening tool in real-world clinics, potentially increasing screening rates.
- What could go wrong
- This is an implementation study, not a test of a new treatment. It focuses on process and may not directly improve health outcomes. Results may vary across clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DARTNet Institute
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spot colorectal cancer early
- Can a Cancer-Fighting virus shrink tumors when chemo fails?
- AI-Powered app aims to transform colorectal cancer recovery monitoring
- One simple score to rate colorectal cancer surgery quality?
- Lab-Made immune protein takes on advanced cancers in first human test
- New PET tracer could spot cancers that standard scans overlook